Stock listing
Launch One Acquisition Corp.
Selected listing: LPAA · NASDAQ · USD · US
Launch One Acquisition Corp. (NASDAQ:LPAA), Finance. Latest release Jan 13, 2026: Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening…
- Ticker
- NASDAQ:LPAA
- Asset type
- Stock
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- NASDAQ
- Currency
- USD
About Launch One Acquisition Corp.
Launch One Acquisition Corp. (ticker: LPAA) is a public company operating in the American market. The company aims to leverage its resources and expertise to drive growth and create value for its shareholders.
Latest news from Launch One Acquisition Corp.
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
January 12, 2026
Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition
November 19, 2025
Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
October 14, 2025
Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome
September 17, 2025
Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers
August 26, 2025
Research Launch One Acquisition Corp.
Launch One Acquisition Corp. company profile
View the public company page for Launch One Acquisition Corp. on 6ix.
Launch One Acquisition Corp. news
Read company news and market updates connected to Launch One Acquisition Corp..
Launch One Acquisition Corp. investor events
Find investor webinars, events, and replay context for Launch One Acquisition Corp..